Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)

13.70 +0.67 (+5.14%) At close: 03:00PM CST

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

No.16 Xuefu Road,High&New Tech Development Zone
Nanjing 210061
China
86 25 8699 0701
https://www.nkf-pharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 1,451

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Tang Yongqun	Chairman & GM	N/A	N/A	1976
Ms. Xiaojie Qian	Financial Manager	N/A	N/A	1980
Dr. Huang Xiwei	Deputy GM, Secretary & Director	N/A	N/A	1970
Ms. Wu Guiping	Deputy General Manager	N/A	N/A	1963

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tigecycline, glycopyrrolate, melphalan, daptomycin, decitabine, haloperidol decanoate, carmustine, bivalirudin, dexmedetomidine, and neostigmine methylsulfate injections. It also offers isosulfan blue, succinylcholine chloride, furosemide, regadenoson, voriconazole, ganirelix acetate, eptifibatide, enoxaparin sodium, mitomycin, vancomycin, micafungin sodium, docetaxel, nelarabine, pemetrexed, rocuronium bromide, zoledronic acid, thiamine, fluorouracil, perixafor, thiotepa, pantoprazole sodium, glatiramer acetate, and bupivacaine hydrochloride injections. The company was founded in 2000 and is based in Nanjing, China.

Corporate governance

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.